Connor, Clark & Lunn Investment Management (CC&L)’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-34,271
Closed -$5.1M 1603
2024
Q3
$5.1M Buy
34,271
+19,787
+137% +$2.84M 0.02% 426
2024
Q2
$1.83M Buy
+14,484
New +$2.27M 0.01% 675
2023
Q3
Sell
-4,172
Closed -$590K 1509
2023
Q2
$590K Sell
4,172
-9,856
-70% -$1.58M ﹤0.01% 943
2023
Q1
$2.36M Sell
14,028
-2,956
-17% -$527K 0.01% 520
2022
Q4
$2.88M Buy
+16,984
New +$3.08M 0.02% 462
2020
Q4
Sell
-20,789
Closed -$3.07M 1018
2020
Q3
$3.07M Buy
20,789
+15,605
+301% +$2.23M 0.02% 396
2020
Q2
$641K Sell
5,184
-37,317
-88% -$4.39M ﹤0.01% 706
2020
Q1
$4.1M Buy
42,501
+14,178
+50% +$1.37M 0.04% 286
2019
Q4
$2.62M Buy
+28,323
New +$2.38M 0.02% 375
2019
Q2
Sell
-5,175
Closed -$306K 1059
2019
Q1
$306K Sell
5,175
-650
-11% -$37.4K ﹤0.01% 752
2018
Q4
$307K Buy
+5,825
New +$342K ﹤0.01% 789
2016
Q1
Sell
-18,875
Closed -$534K 888
2015
Q4
$534K Sell
18,875
-21,175
-53% -$611K ﹤0.01% 532
2015
Q3
$1.11M Buy
40,050
+1,100
+3% +$39.8K 0.01% 381
2015
Q2
$1.61M Sell
38,950
-28,750
-42% -$1.05M 0.01% 267
2015
Q1
$2.06M Buy
67,700
+1,800
+3% +$46.7K 0.02% 228
2014
Q4
$1.3M Buy
65,900
+37,000
+128% +$827K 0.01% 273
2014
Q3
$575K Buy
28,900
+14,000
+94% +$295K ﹤0.01% 372
2014
Q2
$362K Sell
14,900
-90,200
-86% -$1.61M ﹤0.01% 431
2014
Q1
$1.49M Buy
105,100
+35,100
+50% +$503K 0.01% 316
2013
Q4
$1.01M Sell
70,000
-26,200
-27% -$313K 0.01% 365
2013
Q3
$1.1M Buy
96,200
+15,600
+19% +$155K 0.01% 257
2013
Q2
$701K Buy
+80,600
New +$677K 0.01% 310

Other funds holding RGEN

Connor, Clark & Lunn Investment Management (CC&L)'s RGEN Position: Q4 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Repligen (RGEN) in Q4 2024, closing a stake of 34,271 shares — an estimated $5.1M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in RGEN in Q2 2013 and held it in 22 quarters. The position peaked at $5.1M in Q3 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 34,271 Repligen shares in Q4 2024, an estimated $5.1M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Repligen in Q2 2013 and held it in 22 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Repligen position peaked at $5.1M in Q3 2024.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2024, filed 10 Feb 2025.